71 related articles for article (PubMed ID: 7780697)
1. Diagnosis of Alzheimer's disease with commercially available anti-beta peptide (beta A4) antibodies following microwave oven pretreatment.
Liberski PP; Kłoszewska I; Kordek R; Bratosiewicz J; Omulecka A; Papierz W; Alwasiak J
Pol J Pathol; 1995; 46(1):43-6. PubMed ID: 7780697
[TBL] [Abstract][Full Text] [Related]
2. Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody.
Ikeda S; Allsop D; Glenner GG
Lab Invest; 1989 Jan; 60(1):113-22. PubMed ID: 2642985
[TBL] [Abstract][Full Text] [Related]
3. Beta-protein/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer's disease patients.
van de Nes JA; Konermann S; Nafe R; Swaab DF
Acta Neuropathol; 2006 Feb; 111(2):126-38. PubMed ID: 16456666
[TBL] [Abstract][Full Text] [Related]
4. [Alzheimer's disease: immunohistochemical characterization of cerebral amyloid deposits].
Behrouz N; Defossez A; Delacourte A; Hublau P; Mazzuca M
C R Acad Sci III; 1989; 308(16):437-44. PubMed ID: 2543486
[TBL] [Abstract][Full Text] [Related]
5. A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain.
Czasch S; Paul S; Baumgärtner W
Neurobiol Aging; 2006 Feb; 27(2):293-305. PubMed ID: 16002188
[TBL] [Abstract][Full Text] [Related]
6. [Similarities between cerebral amyloid plaques in aged lemurian and in human with Alzheimer's disease].
Bons N; Mestre N
C R Seances Soc Biol Fil; 1993; 187(4):516-25. PubMed ID: 8019922
[TBL] [Abstract][Full Text] [Related]
7. Human monoclonal antibodies against amyloid-beta from healthy adults.
Geylis V; Kourilov V; Meiner Z; Nennesmo I; Bogdanovic N; Steinitz M
Neurobiol Aging; 2005 May; 26(5):597-606. PubMed ID: 15708434
[TBL] [Abstract][Full Text] [Related]
8. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
9. UV light-induced autofluorescence of full-length Abeta-protein deposits in the human brain.
Thal DR; Ghebremedhin E; Haass C; Schultz C
Clin Neuropathol; 2002; 21(1):35-40. PubMed ID: 11846043
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease: glycolytic pretreatment dramatically enhances immunolabeling of senile plaques and cerebrovascular amyloid substance.
Behrouz N; Defossez A; Delacourte A; Hublau P; Mazzuca M
Lab Invest; 1989 Nov; 61(5):576-83. PubMed ID: 2478759
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
[TBL] [Abstract][Full Text] [Related]
12. Development of a monoclonal antibody specific for the COOH-terminal of beta-amyloid 1-42 and its immunohistochemical reactivity in Alzheimer's disease and related disorders.
Murphy GM; Forno LS; Higgins L; Scardina JM; Eng LF; Cordell B
Am J Pathol; 1994 May; 144(5):1082-8. PubMed ID: 8178931
[TBL] [Abstract][Full Text] [Related]
13. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.
Attems J; Lintner F; Jellinger KA
Acta Neuropathol; 2004 Apr; 107(4):283-91. PubMed ID: 14986026
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.
Geylis V; Steinitz M
Autoimmun Rev; 2006 Jan; 5(1):33-9. PubMed ID: 16338209
[TBL] [Abstract][Full Text] [Related]
15. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
Xu BG; Wu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
[TBL] [Abstract][Full Text] [Related]
16. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study.
Attems J; Jellinger KA
Acta Neuropathol; 2004 Feb; 107(2):83-90. PubMed ID: 14655019
[TBL] [Abstract][Full Text] [Related]
17. The presence of a novel protein in calf serum that recognizes beta amyloid in the formalin-fixed section.
Kanemaru K; Hasegawa M; Shimada H; Ihara Y
Am J Pathol; 1990 Sep; 137(3):677-87. PubMed ID: 1698030
[TBL] [Abstract][Full Text] [Related]
18. The immune system, amyloid-beta peptide, and Alzheimer's disease.
Weksler ME; Gouras G; Relkin NR; Szabo P
Immunol Rev; 2005 Jun; 205():244-56. PubMed ID: 15882358
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury.
Ikonomovic MD; Uryu K; Abrahamson EE; Ciallella JR; Trojanowski JQ; Lee VM; Clark RS; Marion DW; Wisniewski SR; DeKosky ST
Exp Neurol; 2004 Nov; 190(1):192-203. PubMed ID: 15473992
[TBL] [Abstract][Full Text] [Related]
20. Immunoaffinity chromatographic purification of amyloid-related proteins from Alzheimer's disease brain tissue.
Landon M; Smith MA; Clarke K; Kidd M
Prog Clin Biol Res; 1989; 317():903-12. PubMed ID: 2574878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
